Prokidney (PROK) Price to Sales (2024 - 2026)
Prokidney's (PROK) quarterly Price to Sales came in at 6952.86 in Q2 2026, up 508.92% year-over-year from 1141.83 in Q2 2025, and up 97.74% quarter-over-quarter from 3516.12 in Q1 2026.
Analysis
Prokidney (PROK) Price to Sales (2024 - 2026) Analysis & Trends
Prokidney (PROK) has reported Price to Sales for 3 consecutive years, with 6952.86 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Sales rose 508.92% year-over-year to 6952.86 in Q2 2026; TTM through Jun 2026 was 1274.97, a 166.27% increase from a year earlier, with the FY2025 full-year figure at 1110.91, down 88.1% from the prior year.
- Price to Sales was 6952.86 for Q2 2026 at Prokidney, up from 3516.12 in the prior quarter.
- Over five years, Price to Sales peaked at 9335.08 in Q4 2024 and troughed at 1141.83 in Q2 2025.
- A 3-year average of 4548.83 and a median of 4409.09 in 2025 frame the typical range for Price to Sales.
- Across the five-year window, Price to Sales plunged 52.77% in 2025 and jumped 508.92% in 2026, its largest moves.
- Over 3 years, Price to Sales stood at 9335.08 in 2024, then sank by 52.77% to 4409.09 in 2025, then surged by 57.69% to 6952.86 in 2026.
- The last three Price to Sales figures came in at 6952.86 (Q2 2026), 3516.12 (Q1 2026), and 4409.09 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,952.86 |
| Mar 31, 2026 | 3,516.12 |
| Dec 31, 2025 | 4,409.09 |
| Sep 30, 2025 | 4,871.36 |
| Jun 30, 2025 | 1,141.83 |
| Mar 31, 2025 | 1,615.50 |
| Dec 31, 2024 | 9,335.08 |